Format

Send to

Choose Destination
See comment in PubMed Commons below
Future Oncol. 2011 Feb;7(2):299-307. doi: 10.2217/fon.10.184.

Predictive markers of colorectal cancer liver metastases.

Author information

1
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 444 E 68th Street, New York, NY 10065, USA.

Abstract

Liver metastases are the most common site of distant failure after curative resection of colorectal cancer and a source of significant cancer-related morbidity and mortality. Currently, imaging and conventional histopathologic features, such as T-stage and N-stage, are used by clinicians to inform prognosis and guide adjuvant treatment to reduce the risk of developing distant metastases. However, these tools only have a moderate ability to predict the development of liver metastases. Novel methods, including the detection of circulating tumor cells and carcinoembryonic antigens in serum, have been developed, and their prognostic and predictive characteristics have been assessed. In addition, several molecular and genetic markers in the primary tumor have been studied. Unfortunately, these studies are often small and their results have been mixed, yielding no consistent sets of externally validated predictors of colorectal liver metastases. For widespread clinical relevance, future tests need to be independently carried out on large independent patient samples.

PMID:
21385143
DOI:
10.2217/fon.10.184
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center